MR-107A-01
/ Viatris
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 13, 2021
Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
(clinicaltrials.gov)
- P2; N=114; Completed; Sponsor: Mylan Inc.; Recruiting ➔ Completed
Clinical • Trial completion • Pain
October 23, 2020
Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
(clinicaltrials.gov)
- P2; N=110; Recruiting; Sponsor: Mylan Inc.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Pain
October 01, 2020
Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
(clinicaltrials.gov)
- P2; N=110; Not yet recruiting; Sponsor: Mylan Inc.
Clinical • New P2 trial • Pain
1 to 3
Of
3
Go to page
1